Passage Bio, Inc.
PASGNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $11.55M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $3.29$20.00
- Volume (live)
- -
- Avg. volume (3M)
- 26.98K
Passage Bio (PASG) Stock Price & Financial Analysis
Passage Bio Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.37 - $3.76 |
|---|---|
| 52-Week High | $20.00 |
| 52-Week Low | $3.29 |
| Open | $3.61 |
| Volume (last close) | 16.80K |
| Average Volume (3M) | 26.98K |
| 50-Day MA | $4.52 |
|---|---|
| 200-Day MA | $6.96 |
| 1-Year Change | −55.39% |
| Market Cap | 11.55M |
|---|---|
| Shares Outstanding | 3.21M |
| Price to Book (P/B) | 2.59 |
| EV/EBITDA | 0.35 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Passage Bio at a Glance
As of the Oct 16, 2026 close, Passage Bio (PASG) has a market capitalization of $11.55M.
As of its latest reported balance sheet, it holds $24.16M in cash and securities against $0.00 of debt, a net cash position of $24.16M.
Passage Bio does not currently pay a dividend.
The share price is down 55.4% over the past year. At $3.50 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $3.29 to $20.00, below its 200-day moving average of $6.96.
Based on 1 professional analyst rating from the past 90 days, the consensus is Hold.
Frequently Asked Questions About Passage Bio
What is the current stock price for PASG?
As of the Oct 16, 2026 close, PASG stock trades at $3.50. The 52-week range is $3.29–$20.00, with a day range of $3.37–$3.76.
What is the P/E ratio for PASG?
The P/E ratio (Price-to-Earnings) for PASG is shown in the Key Statistics section. This valuation metric helps compare Passage Bio, Inc. to industry peers.
Does PASG pay dividends?
Passage Bio does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for PASG?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for PASG is Hold.
What is the market cap of PASG?
As of the Oct 16, 2026 close, Passage Bio's market capitalization is $11.2M, classifying it as a micro-cap company. Passage Bio operates in the Healthcare sector within the Biotechnology industry.